Can a simple Nurse-Led program help older heart patients live healthier after stent surgery?

NCT ID NCT07683143

What the study statuses mean

This study's is highlighted.

Recruitment status, easiest to join first

Recruiting now
This trial is taking on new participants right now.
Not yet recruiting
Registered, but not yet taking participants.
By invitation only
Not open to general applications. Only people the study team invites can take part.
Paused
Paused for now. It may or may not start again.
Ongoing
Running, but no longer taking on new participants.
Completed This study
The trial has finished. Results may not be published yet.
Stopped early
Stopped early, before it reached the end. That can be for many reasons, including safety.
Cancelled
Cancelled before anyone took part.

Expanded access (not trials)

Expanded access
Not a trial. This treatment can be requested outside a study, case by case, for people who qualify.
Expanded access (paused)
Not a trial. The treatment can normally be requested outside a study, but is unavailable right now.
Expanded access (ended)
Not a trial. The treatment could once be requested outside a study, but no longer can.
Approved
The treatment has been approved, so it is available normally rather than through this programme.

When the status isn't known

Details not published
The full record has not been published yet, so there is little to show here.
Status unknown
This status has not been confirmed recently, so it may be out of date.

First seen Jul 06, 2026 · Last updated Jul 07, 2026 · Updated 1 time

Summary

This study tests a nurse-led program designed to help elderly patients (age 60+) adopt healthier behaviors after undergoing a heart stent procedure (PCI). The program provides information, motivation, and practical skills through in-person sessions, phone calls, and hands-on training. Researchers will compare the program to standard care to see if it improves health-promoting behaviors, self-confidence, and quality of life.

What this could mean

Our plain-language read of the trial. This is informational only, not medical advice or a prediction.

Active substance
nurse-led behavioral intervention
What this could lead to
If effective, this program could become a standard approach to help elderly heart patients adopt healthier lifestyles after stent surgery.
What could go wrong
This is a small, early-stage study with 78 participants, so results may not apply broadly. The intervention relies on patient motivation and may not work for everyone.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Study facts

What this study's own registry entry says, in plain language.

Phase

Not a phased trial

Phase numbers describe drug development. The registry uses this when they do not apply, as it does for trials of devices, procedures or behaviour changes, and for observational studies.

Participants

78 people

The number who actually took part.

Started

May 2025

Finished

Nov 2025

Lead sponsor

Other sponsor

The registry's catch-all category, for sponsors it does not file as a company, a government agency, or a research network.

Who can take part

This study's own entry requirements. Only the study team can say for certain whether you qualify.

Ages

60 years and older

Sex

Anyone

Healthy volunteers

Not accepted

This study is not open to healthy volunteers. The entry requirements below say who it is open to.

Show the full entry requirements

Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.

Inclusion criteria: 1. a confirmed diagnosis of coronary heart disease with a stable condition following PCI 2. age ≥60 years 3. normal cognitive and communication abilities 4. provision of written informed consent and voluntary participation in the study Exclusion criteria: 1. severe concomitant diseases affecting vital organs (e.g., liver, brain, or kidneys) 2. current participation in other similar studies

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for Coronary heart disease are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Huaihe Hospital of Henan University

    Kaifeng, Henan, 475000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.